Related Experiment Video
Updated: Jul 19, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
Update on protozoan parasites of the intestine
Andrea N Davis1, Rashidul Haque, William A Petri
1Department of Medicine, University of Virginia Health Sciences System, Charlottesville, Virginia 22908, USA.
Abstract:
The last year has seen new approaches to the diagnosis, treatment, and prevention of protozoal infections of the gastrointestinal tract. Some of the news is not good: new foodborne and swimming pool outbreaks of cyclosporiasis and cryptosporidiosis, respectively, occurred in North America; paromomycin was shown to be ineffective treatment for cryptosporidiosis; and these parasitic diseases continued to have a worldwide impact on human health. On the bright side, there were important advances in the understanding of the pathogenesis of cryptosporidiosis and the diagnosis of amebiasis and giardiasis, and some new leads on the treatment of cryptosporidiosis and refractory giardiasis. Finally, evidence was found of acquired mucosal immunity to amebiasis in Bangladeshi children, offering a guide for the development of an amebiasis vaccine. This review is not intended to be comprehensive, but contains a variety of articles that the authors hope will be of interest to the reader.
Insights
Recent advances in diagnosing and treating gastrointestinal protozoal infections show mixed results. New outbreaks of cyclosporiasis and cryptosporidiosis occurred, but progress was made in understanding pathogenesis and developing vaccines.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Parasitology
Background:
- Gastrointestinal protozoal infections pose a significant global health challenge.
- Recent outbreaks of cyclosporiasis and cryptosporidiosis highlight ongoing public health concerns.
- Existing treatments for some protozoal infections remain limited, necessitating new therapeutic strategies.
Purpose of the Study:
- To review recent developments in the diagnosis, treatment, and prevention of gastrointestinal protozoal infections.
- To highlight advances in understanding the pathogenesis of cryptosporidiosis.
- To explore new therapeutic leads for cryptosporidiosis and giardiasis, and potential vaccine development for amebiasis.
Main Methods:
- Literature review of recent studies on protozoal gastrointestinal infections.
- Analysis of outbreak data for cyclosporiasis and cryptosporidiosis.
- Evaluation of treatment efficacy studies for cryptosporidiosis and giardiasis.
- Review of research on amebiasis pathogenesis and immunity.
Main Results:
- New outbreaks of cyclosporiasis and cryptosporidiosis occurred in North America.
- Paromomycin demonstrated ineffectiveness in treating cryptosporidiosis.
- Advances were made in diagnosing amebiasis and giardiasis, and in understanding cryptosporidiosis pathogenesis.
- Potential new treatments for cryptosporidiosis and refractory giardiasis were identified.
- Evidence of acquired mucosal immunity to amebiasis in children suggests vaccine development is feasible.
Conclusions:
- Despite challenges like new outbreaks and treatment failures, significant progress has been made in understanding and managing gastrointestinal protozoal infections.
- Research into pathogenesis and immunity is paving the way for improved diagnostics and novel interventions, including vaccines.
- Continued research is crucial to address the worldwide impact of these parasitic diseases.
Related Concept Videos
Amebiasis
Giardiasis
Diversity of Protists I
Diversity of Protists II
Trichomoniasis
Overview of Protists
